ASTRAZENECA PLC (AZN)
Clinical trial NCT03668340 updates: 1. completion date: 2027-07-01 → 2027-09-01 2. primary completion date: 2026-07-01 → 2026-09-01
Clinical trial NCT03668340 updates: 1. completion date: 2027-07-01 → 2027-09-01 2. primary completion date: 2026-07-01 → 2026-09-01
📉 **NEGATIVE** • Medium confidence analysis (61%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (25%) **Content type:** Clinical